Effectiveness of Convalescent Plasma Therapy for COVID-19 Patients in Hunan, China
Objective: To investigate clinical efficacy and safety of convalescent plasma (CP) therapy in coronavirus disease 2019 (COVID-19) patients. Methods: We included 4 severe patients and 3 critical patients. The date of admission to hospital ranged from January 30 to February 19, 2020. We retrospectivel...
Main Authors: | Xingsheng Hu, Chunhong Hu, Dixuan Jiang, Qian Zuo, Ya Li, Yang Wang, Xiangyu Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2020-12-01
|
Series: | Dose-Response |
Online Access: | https://doi.org/10.1177/1559325820979921 |
Similar Items
-
Finding the Best Antiviral Regimen for COVID-19: A Double-Center Retrospective Cohort Study of 207 Cases in Hunan, China
by: Xingsheng Hu, et al.
Published: (2020-08-01) -
Clinical characteristics and risk factors for severity of COVID-19 outside Wuhan: a double-center retrospective cohort study of 213 cases in Hunan, China
by: Xingsheng Hu, et al.
Published: (2020-10-01) -
Convalescent (Immune) Plasma Therapy and COVID-19
by: Viroj Wiwanitkit
Published: (2020-11-01) -
Convalescent COVID-19 plasma
by: Vavić Nataša, et al.
Published: (2021-01-01) -
Facts and challenges in convalescent plasma therapy in COVID-19
by: Kumar H
Published: (2020-12-01)